Affiliation:
1. National Institutes of Health, Ministry of Health
Abstract
Abstract
Background
Point-of-care testing (POCT) is commonly used in epidemiological surveys due to its various advantages, such as portability and immediate test results. The CardioChek® PA analyser 3-in-1 lipid panel measures total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol. This study tested the reliability and diagnostic accuracy of the CardioChek® PA analyser using a 3-in-1 lipid panel.
Methods
A cross-sectional study design with quota sampling was used. A total of 203 respondents aged 18 years and above from a research centre in the Ministry of Health, Malaysia, were recruited. Venous blood was sent to the laboratory, while a POCT analyser was used for capillary blood measurements. Intraclass coefficient correlation (ICC) analysis was employed to determine the agreement between capillary and venous blood parameters. The diagnostic performance of the evaluated tests was evaluated using STATA version 12.
Results
The agreement between capillary and laboratory venous blood was moderate (0.64–0.67) for TC and HDL, good (0.75) for LDL and excellent (0.91) for TG). The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were as follows: TC, 57.1%, 94.3%, 92.3% and 64.8%; TG, 76.0%, 100%, 100%, and 96.6%; HDL, 96.2%, 83.2%, 47.2% and 99.3%; and LDL, 81.0%, 100%, 100% and 68.3%, respectively.
Conclusions
The CardioChek® PA analyser showed acceptable diagnostic accuracy for screening high-risk individuals more often in places where laboratories are inaccessible. It could also be used in clinical settings where patients would benefit from swift treatment decisions.
Publisher
Research Square Platform LLC
Reference31 articles.
1. World Health Organization (WHO). Noncommunicable diseases [Internet]. 2021 [cited 2022 Feb 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.
2. Wengrofsky P, Lee JMA. Dyslipidemia and Its Role in the Pathogenesis of Atherosclerotic Cardiovascular Disease: Implications for Evaluation and Targets for Treatment of Dyslipidemia Based on Recent Guidelines. In: SI M, editor. IntechOpen; 2019. Available from: https://www.intechopen.com/chapters/66725 10.5772/intechopen.85772.
3. Global Trends in the Epidemiology and Management of Dyslipidemia;Liu T;J Clin Med,2022
4. Institute for Public Health. National Health and Morbidity Survey (NHMS). 2019: NCDs - Non-Communicable Diseases: Risk Factors and other Health Problems [Internet]. Vol. 1, Institute for Public Health, National Institutes of Health (NIH), Ministry of Health Malaysia. 2019. Available from: https://iku.moh.gov.my/images/IKU/Document/REPORT/NHMS2019/Report_NHMS2019-NCD_v2.pdf.
5. Hypercholesterolemia Prevalence, Awareness, Treatment and Control among Adults in Malaysia: The 2015 National Health and Morbidity Survey, Malaysia;Mat Rifin H;Glob J Health Sci,2018